Clinical Evidence: How Wegovy and Mounjaro Compare
Is Wegovy Same as Mounjaro? Understanding the Key Differences
Wegovy and Mounjaro are fundamentally different prescription-only medicines, despite both being used for weight management in UK adults. Wegovy contains semaglutide, a selective GLP-1 receptor agonist that mimics your body's natural fullness hormone. Mounjaro contains tirzepatide, which targets both GIP and GLP-1 receptors simultaneously, creating a dual-action approach. This difference in mechanism means they work through distinct pathways in your body, though both require clinical assessment and prescription from a qualified healthcare provider. Neither treatment is "the same" as the other, and your prescriber at EverydayMeds can help determine which mechanism may be more suitable for your individual circumstances.
The storage requirements also differ significantly when comparing whether Wegovy is the same as Mounjaro practically. Wegovy offers superior travel convenience, maintaining stability at room temperature for up to 6 weeks once removed from refrigeration. Mounjaro requires return to refrigeration within 21 days of removal. Both medications use different injection devices and have distinct dose escalation schedules, making them operationally different treatments despite serving similar weight management goals.
UK Pricing: Wegovy vs Mounjaro Value Comparison
When considering if Wegovy is the same as Mounjaro from a cost perspective, pricing structures differ significantly. Wegovy at EverydayMeds starts from £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the maintenance 2.4mg dose. New customers apply code FIRST40 at checkout to reach these prices, while returning customers use DOSE25. Our bundle options provide supply convenience, with the Intro Duo (0.25mg & 0.5mg) priced at £169.99 for your first 8 weeks of treatment. Mounjaro pricing follows a different structure entirely, and both treatments require the same rigorous clinical assessment process.
Bundle pricing for Wegovy reflects the convenience of Reliable Supply rather than cost savings, with our Ultimate Stability Trio providing three months of maintenance 2.4mg doses for £649.99. This eliminates multiple ordering cycles and ensures consistent cold-chain delivery throughout your treatment journey. Neither Wegovy nor Mounjaro represents a "cheaper" option universally, as individual dosing requirements and treatment duration vary based on clinical response and prescriber guidance from our GPhC-registered pharmacy team (#9012878).
STEP Trial Evidence: Is Wegovy Same as Mounjaro for Results?
Clinical trial evidence demonstrates that Wegovy and Mounjaro are not the same in terms of study populations or trial designs, making direct comparison inappropriate. In the STEP 1 trial, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 3 trial showed approximately clinically studied weight loss when combined with intensive behavioural therapy, while STEP 5 demonstrated sustained clinically studied weight loss at 2 years.
Mounjaro's clinical evidence comes from separate SURMOUNT trials with different methodologies and patient populations, preventing direct percentage comparisons. Both treatments have demonstrated cardiovascular benefits, with Wegovy's SELECT trial showing 20% reduction in major cardiovascular events. Individual results vary significantly, and neither treatment ensures specific outcomes, as weight management depends on multiple factors including diet, exercise, and individual metabolic response.
Mechanism Differences: How Each Treatment Works
Understanding whether Wegovy is the same as Mounjaro requires examining their distinct mechanisms of action within your body's weight regulation systems. Wegovy works exclusively through GLP-1 receptor activation, mimicking the natural incretin hormone that signals fullness to your brain after eating. This reduces appetite, slows gastric emptying, and promotes satiety with smaller meal portions. The single-pathway approach creates targeted effects on appetite centres in the hypothalamus, leading to reduced food intake and decreased cravings between meals. Wegovy must be used alongside a reduced-calorie diet and increased physical activity as part of a comprehensive weight management programme.
EverydayMeds Ordering Process: Both Treatments Available
Whether you're considering Wegovy or Mounjaro, EverydayMeds provides both treatments through the same streamlined clinical assessment process. Complete our 3-minute online questionnaire covering your medical history, current medications, and weight management goals. Our qualified prescribers review your assessment within 3 working days (24-hour express option available), ensuring clinical suitability for your chosen treatment. Upon approval, we dispatch your prescription-only medicine via next-day cold-chain delivery, maintaining optimal temperature throughout transit. Both Wegovy and Mounjaro require identical clinical oversight and safety monitoring throughout your treatment journey with our GPhC-registered pharmacy (#9012878).
Storage and Practical Considerations
Daily practical use reveals why Wegovy is not the same as Mounjaro beyond their clinical mechanisms. Wegovy uses Novo Nordisk's FlexTouch pen technology, pre-filled with specific doses for each treatment week. Store unused pens in your refrigerator at 2-8°C, with the significant advantage of 6-week room temperature stability once removed. This makes Wegovy ideal for travel, holidays, or situations where refrigeration access is limited. Both treatments require once-weekly injection, but Wegovy's dose escalation follows a specific 16-week schedule: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), then 2.4mg maintenance dose from week 17 onwards.
UK Clinical Context: Why Both Options Matter
The question "is Wegovy same as Mounjaro" reflects the importance of personalised weight management approaches in UK clinical practice. Some patients respond optimally to Wegovy's targeted GLP-1 mechanism, while others may benefit from Mounjaro's dual-pathway approach. Factors including existing medical conditions, medication interactions, lifestyle requirements, and individual metabolic profiles influence treatment selection. NICE guidelines emphasise individualised treatment decisions based on clinical assessment rather than assuming equivalent outcomes between different weight management medicines.
EverydayMeds' prescribers consider your complete clinical picture when recommending between Wegovy and Mounjaro, ensuring optimal treatment matching for your circumstances. Neither treatment represents a universally superior option, as both have demonstrated significant clinical efficacy in their respective trial populations. Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which is right for you based on comprehensive clinical evaluation.
Start Your Clinical Assessment Today
Ready to explore whether Wegovy or Mounjaro aligns with your weight management goals? Begin with EverydayMeds' clinical assessment at https://everydaymeds.co.uk/collections/wegovy, where our qualified prescribers evaluate both treatment options for your individual needs. New customers apply code FIRST40 at checkout, while returning customers use DOSE25 to access our competitive UK pricing. Our clinical team provides ongoing support throughout your treatment journey, ensuring safe and effective weight management with whichever prescription-only medicine proves most suitable. Don't spend more time wondering if Wegovy is the same as Mounjaro – get professional clinical guidance to make an informed treatment decision. Contact EverydayMeds today for expert weight management support tailored to your individual requirements and clinical profile.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
